Comparison / Level C vs Level D

Delta Sleep-Inducing Peptide (DSIP) vs Pinealon

Research Verdict

Neither compound has a universal evidence advantage. Research distinction: Sleep architecture research with access to historical human EEG data from DSIP studies vs. Pineal gland biology research within the Khavinson peptide bioregulator framework.

Quick Answers

Which is better, Delta Sleep-Inducing Peptide (DSIP) or Pinealon?

Neither compound has a universal evidence advantage. Research distinction: Sleep architecture research with access to historical human EEG data from DSIP studies vs. Pineal gland biology research within the Khavinson peptide bioregulator framework.

What is the key difference between Delta Sleep-Inducing Peptide (DSIP) and Pinealon?

DSIP is a nonapeptide with demonstrated delta-wave EEG effects in early human studies; pinealon is a Khavinson tripeptide targeting pineal function - DSIP has more neurophysiological characterization despite its age.

Evidence Comparison

DSIP: 1970s-era human sleep studies (uncontrolled), animal EEG data. Pinealon: Khavinson tripeptide, single research group, minimal published data. DSIP has more historical data; neither meets modern evidence standards.

Evidence Context Favoring Delta Sleep-Inducing Peptide (DSIP)

Sleep architecture research with access to historical human EEG data from DSIP studies.

Evidence Context Favoring Pinealon

Pineal gland biology research within the Khavinson peptide bioregulator framework.

Side-by-Side Snapshot

Evidence gradeDelta Sleep-Inducing Peptide (DSIP): Level C
Pinealon: Level D
Research statusDelta Sleep-Inducing Peptide (DSIP): Preclinical
Pinealon: Early Research
Primary categoryDelta Sleep-Inducing Peptide (DSIP): Anti-Aging & Longevity
Pinealon: Cognitive & Nootropic
Cited studiesDelta Sleep-Inducing Peptide (DSIP): 2
Pinealon: 2

Read Next